Ghosh A, Pillai R, Vij J, Maulik P, Bhanker N, Thakur U
Indian J Psychol Med. 2025; :02537176241313210.
PMID: 39911791
PMC: 11790474.
DOI: 10.1177/02537176241313210.
Tu J, Shaw R, Florimbio A, McCarthy K, Bonar E, Chermack S
Addict Behav Rep. 2024; 20:100572.
PMID: 39659896
PMC: 11629558.
DOI: 10.1016/j.abrep.2024.100572.
Oo M, Shukalek C, Kishibe T, Hull M, Tan D
BMJ Open. 2024; 14(11):e090565.
PMID: 39515851
PMC: 11552022.
DOI: 10.1136/bmjopen-2024-090565.
Palfai T, Bernier L, Kratzer M, Magane K, Fielman S, Otis J
Addict Sci Clin Pract. 2024; 19(1):64.
PMID: 39238059
PMC: 11375999.
DOI: 10.1186/s13722-024-00493-3.
Paquette C, Vierling A, Kane L, Linares Abrego P, Benson K, Jordan E
J Subst Use Addict Treat. 2024; 167:209490.
PMID: 39179209
PMC: 11612634.
DOI: 10.1016/j.josat.2024.209490.
Executive function and adult homelessness, true impairment or frontal lobology?.
Pluck G
Front Hum Neurosci. 2024; 18:1359027.
PMID: 38322781
PMC: 10844389.
DOI: 10.3389/fnhum.2024.1359027.
Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials.
Amin-Esmaeili M, Farokhnia M, Susukida R, Leggio L, Johnson R, Crum R
Addiction. 2024; 119(5):833-843.
PMID: 38197836
PMC: 11009085.
DOI: 10.1111/add.16409.
Association of Alcohol Consumption With CD4 Recovery After Antiretroviral Therapy Initiation in St. Petersburg, Russia.
McLaughlin A, Lin N, Jiang W, Lodi S, Lioznov D, Patts G
J Acquir Immune Defic Syndr. 2023; 94(3):244-252.
PMID: 37850982
PMC: 10593489.
DOI: 10.1097/QAI.0000000000003250.
Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trial.
Edelman E, Dziura J, Deng Y, DePhilippis D, Fucito L, Ferguson T
Contemp Clin Trials. 2023; 131:107242.
PMID: 37230168
PMC: 10460633.
DOI: 10.1016/j.cct.2023.107242.
Patient-Reported Outcomes Collection at an Urban HIV Clinic Associated With a Historically Black Medical College in the Southern United States: Qualitative Interview Study Among Patients With HIV.
Parisot Iii P, Wheeler F, Bonnet K, Rebeiro P, Schember C, McCainster K
JMIR Form Res. 2023; 7:e42888.
PMID: 36947109
PMC: 10132038.
DOI: 10.2196/42888.
Contingency Management and Pre-Exposure Prophylaxis Adherence Support Services (CoMPASS): A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs.
Sung M, Viera A, Esserman D, Tong G, Davidson D, Aiudi S
Contemp Clin Trials. 2022; 125:107037.
PMID: 36460267
PMC: 9918697.
DOI: 10.1016/j.cct.2022.107037.
Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use.
Spaderna M, Kattakuzhy S, Kang S, George N, Bijole P, Ebah E
Int J Drug Policy. 2022; 111:103906.
PMID: 36384062
PMC: 9868066.
DOI: 10.1016/j.drugpo.2022.103906.
Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL): A cross-sectional observational study protocol using respondent driven sampling.
Carney T, Rooney J, Niemand N, Myers B, Theron D, Wood R
PLoS One. 2022; 17(2):e0262440.
PMID: 35167586
PMC: 8846525.
DOI: 10.1371/journal.pone.0262440.
The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial.
Whiteside L, Huynh L, Morse S, Hall J, Meurer W, Banta-Green C
J Subst Abuse Treat. 2021; 136:108666.
PMID: 34952745
PMC: 9056018.
DOI: 10.1016/j.jsat.2021.108666.
A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis.
Blevins D, Seneviratne C, Wang X, Johnson B, Ait-Daoud N
Drug Alcohol Depend. 2021; 228:109074.
PMID: 34600264
PMC: 8595865.
DOI: 10.1016/j.drugalcdep.2021.109074.
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment.
Hill K, Nussdorf L, Mount J, Silk R, Gross C, Sternberg D
J Addict Med. 2021; 16(1):10-17.
PMID: 33560694
PMC: 8923533.
DOI: 10.1097/ADM.0000000000000807.
Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain.
Cunningham C, Starrels J, Zhang C, Bachhuber M, Sohler N, Levin F
BMJ Open. 2020; 10(12):e043400.
PMID: 33376181
PMC: 7778768.
DOI: 10.1136/bmjopen-2020-043400.
Sexual discounting: A systematic review of discounting processes and sexual behavior.
Johnson M, Strickland J, Herrmann E, Dolan S, Cox D, Berry M
Exp Clin Psychopharmacol. 2020; 29(6):711-738.
PMID: 33001694
PMC: 8977071.
DOI: 10.1037/pha0000402.
Attention-Deficit/Hyperactivity Disorder Symptoms Are Associated with Greater Delay Discounting of Condom-Protected Sex and Money.
Berry M, Sweeney M, Dolan S, Johnson P, Pennybaker S, Rosch K
Arch Sex Behav. 2020; 50(1):191-204.
PMID: 32328913
DOI: 10.1007/s10508-020-01698-8.
Exposure to HIV risks among young people who use drugs (YPUD) in three cities in Vietnam: time to develop targeted interventions.
Michel L, Nguyen L, Nguyen A, Ekwaru J, Laureillard D, Nagot N
Harm Reduct J. 2020; 17(1):13.
PMID: 32093700
PMC: 7038548.
DOI: 10.1186/s12954-020-00357-4.